One World Products (OWPC) Change in Accured Expenses (2014 - 2025)
One World Products (OWPC) recorded quarterly Change in Accured Expenses of $329168.0 in Q3 2025, up 1140.36% quarter-over-quarter from $26538.0 in Q2 2025, and up 250.81% on a YoY basis from $93830.0 in Q3 2024.
One World Products (OWPC) Change in Accured Expenses (2014 - 2025) Analysis & Trends
One World Products' Change in Accured Expenses history runs 12 years deep, the most recent figure standing at $329168.0 for Q3 2025.
- In Q3 2025, Change in Accured Expenses rose 250.81% year-over-year to $329168.0; the TTM figure through Sep 2025 stood at $71896.0 (down 85.82% YoY), while the FY2024 annual figure was -$80637.0, down 117.03% from the prior year.
- Change in Accured Expenses was $329168.0 for Q3 2025 at One World Products, up from $26538.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $329168.0 in Q3 2025 to a low of -$404285.0 in Q4 2024.
- Historically, Change in Accured Expenses has averaged $66792.7 across 5 years, with a median of $93830.0 in 2024.
- The sharpest annual moves came in 2021 and 2022: Change in Accured Expenses plunged 1707.44% in 2021, then soared 4756.38% in 2022.
- A 5-year view of Change in Accured Expenses shows it stood at $4607.0 in 2021, then soared by 2833.45% to $135144.0 in 2022, then soared by 35.76% to $183476.0 in 2023, then slumped by 320.35% to -$404285.0 in 2024, then surged by 181.42% to $329168.0 in 2025.
- The last three Change in Accured Expenses figures came in at $329168.0 (Q3 2025), $26538.0 (Q2 2025), and $120475.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | One World Products | - | - | 48,591.00 | 329,168.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 329,168.00 |
| Sep 30, 2025 | 329,168.00 |
| Jun 30, 2025 | 26,538.00 |
| Jun 30, 2025 | 26,538.00 |
| Mar 31, 2025 | 120,475.00 |
| Mar 31, 2025 | 120,475.00 |
| Dec 31, 2024 | -404,285.00 |
| Dec 31, 2024 | -404,285.00 |
| Sep 30, 2024 | 93,830.00 |
| Sep 30, 2024 | 93,830.00 |
| Jun 30, 2024 | 89,869.00 |
| Jun 30, 2024 | 89,869.00 |
| Mar 31, 2024 | 139,949.00 |
| Mar 31, 2024 | 139,949.00 |
| Dec 31, 2023 | 183,476.00 |
| Dec 31, 2023 | 183,476.00 |
| Sep 30, 2023 | -37,032.00 |
| Sep 30, 2023 | -37,032.00 |
| Jun 30, 2023 | 155,786.00 |
| Jun 30, 2023 | 155,786.00 |